Pharmaceutical Technology

OCTOBER 31, 2022

On receiving approval, the treatment is expected to replace the requirement to use unapproved repackaged oncologic IV bevacizumab from compounding pharmacies for wet AMD treatment. It is also developing registration documents for approvals in Europe, with submission expected in the fourth quarter of this year.

Labelling 59

Labelling Compounding Pharmacies Compounding Documentation 59

epicur

NOVEMBER 10, 2022

If so, did you document it? Answering no to either of those documentation questions could mean your practice is at risk. 5 Reminders for Properly Documenting a Spilled or Broken Bottle of a Controlled Substance A spill or breakage does not constitute a loss because the registrant can account for the controlled substance.

Controlled Substances 52

Controlled Substances Documentation Compounding Pharmacies Compounding 52

epicur

AUGUST 8, 2023

Implementation of GFI #256 Earlier this year, the FDA finalized regulatory guidance for compounded medications, known as GFI #256. If GFI is affecting your practice’s ability to get compounded medications for office use, partnering with a trusted 503B outsourcing facility can help you eliminate risks of limited ordering.

Compounding 52

Compounding Documentation Compounding Pharmacies Packaging 52

Quality Matters

AUGUST 3, 2023

While focuses on evaluating and establishing supplier reliability for pharmaceutical manufacturing companies and compounding pharmacies, its high-level elements of supplier qualification can also be applied to suppliers of foods and dietary supplement ingredients.

Packaging 52

Packaging Compounding Pharmacies Pharmaceutical Manufacturing Documentation 52

Pharmacy Times

JULY 2, 2025

They can collect documentation on prior preventive therapies, baseline MMDs, and follow-up outcomes to support prior authorization, including site-of-care arrangements. of participants discontinued due to adverse effects.

Pharmacy Technician 52

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 52

Express Pharma

JUNE 20, 2025

Archive design basis documents for all facility, process, and utility decisions. Treat each deviation, complaint, or EM excursion as a rehearsal for an FDA discussion – document decisions, risk rationales, and CAPAs with inspection-grade clarity. Regularly conduct mock inspections using external or cross-site auditors.

Documentation 63

Documentation Compounding Compounding Pharmacies Pharmaceutical Manufacturing 63

Pharmacy Times

JULY 9, 2025

2 Evidence Supporting Supplementation A randomized controlled trial involving high-dose vitamin D (300 IU/kg/day, up to 5000 IU/day) in children with ASD documented meaningful improvements in Childhood Autism Rating Scale (CARS) scores, repetitive behaviors, eye contact, and attention after 4 months, without toxicity.

Pharmacy Technician 40

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 40

Pharmacy Times

JUNE 9, 2025

Pulmonary function tests and provider documentation were manually reviewed to confirm asthma diagnoses, while individuals with other pulmonary diseases were excluded. 1 The study also observed that 65% of patients had a documented visit with an asthma specialist during the follow-up period.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 29

Pharmacy Times

JUNE 17, 2025

If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. Results American Oncology Network (AON) Pharmacy collected data on waste and cost avoidance from February 2023 to September 2023. During this time frame, the pharmacy documented 152 interventions.

Mail-Order Pharmacies 29

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient 29

Pharmacy Times

JUNE 20, 2025

It’s also helpful to hear from managed care experts—understanding their concerns and what documentation is needed to ensure patients can get coverage for the latest treatments. I love that OPC is positioned so close to ASCO because pharmacists often can’t attend large meetings due to travel restrictions and limited funding.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Immunity Immunization 26

Pharmacy Times

JUNE 23, 2025

We just must do a good job of documenting them and develop that clinical evidence base that supports it. Pharmacy Times: How do evolving guidelines influence the integration of CGMs into standard clinical practice for T2D? It's time for another compound. That's the only unanimous thing in the whole survey.

Diabetes 26

Diabetes Pharmacy Technician Compounding Pharmacies Compounding 26

Pharmacy Times

JUNE 20, 2025

Other documented causes of secondary dysmenorrhea include fibroids, adenomyosis, infection, myomas, obstructive reproductive tract anomalies, and ovarian cysts About the Author Yvette C. Dysmenorrhea, also known as painful menstruation, is the most commonly reported menstrual symptom among females during the reproductive years.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 26

Pharmacy Times

JULY 2, 2025

The manufacturer reported that, as part of the NDA review, they have not highlighted any technical concerns related to the submitted documentation or testing of OLC. The CRL was received after OLC’s initial Prescription Drug User Fee Act date of June 28, 2025, and cited for deficiencies that are unrelated to OLC itself.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Pharmacy Management Adverse Reactions 29

Pharmacy Times

JULY 1, 2025

We all share the same electronic health record and document every patient interaction in the health record, and we have very easy access to reach out to the patient's provider to let them know of any questions or concerns that the patient has regarding their medication.

Insurance Coverage and Processing 26

Insurance Coverage and Processing Pharmacy Technician Specialty Pharmacies Compounding Pharmacies 26

Pharmacy Times

JUNE 22, 2025

Pharmacy Times: What are the most significant benefits of CGM adoption for individuals with type 2 diabetes? Sayer: The most documented, most significant benefits If you take a look at the trials we've run, first of all, you always see an A1c reduction, because average glucose values go down and A1c follows.

Diabetes 26

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 26